Validation of the French Version of the Perinatal Assessment of Paternal Affectivity (PAPA)
French-Papa
Cross-cultural Adaptation and Validation of the French Version of the PAPA (Perinatal Assessment of Paternal Affectivity) Self-questionnaire Assessing the Psychological Experience of Fathers Pre- and Post-natal
1 other identifier
observational
340
1 country
1
Brief Summary
The transition to parenthood is a critical period for both the woman and her partner, and this can affect the mental health of the parents. Like mothers, fathers are at risk of stress, anxiety, depression and post-traumatic stress disorder during the perinatal period. Existing screening or diagnostic tools have been developed on the basis of traditional depressive symptoms expressed by women. However, the manifestations of perinatal mental disorders appear to be different in men. It is therefore essential to develop tools that are sensitive and specific to both gender and the perinatal period in order to increase the sensitivity and specificity of screening for fathers. In France, to the best of the knowledge of the investigators, there is no validated tool in French to assess paternal psychological disorders, either prenatally or postnatally. Baldoni et al. had validated a brief self-report questionnaire, the " Perinatal Assessment of Paternal Affectivity " (PAPA), to screen for perinatal signs and symptoms of paternal affective disorder, using a gender-sensitive approach. The aim of this study is to cross-cultural adapt the PAPA in French and to evaluate its psychometric properties. This validation of the French-PAPA would provide a simple tool, easy to use in everyday practice, to detect any signs or symptoms of paternal psychopathological distress in the pre- and postnatal period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 10, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedStudy Start
First participant enrolled
October 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 18, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 18, 2026
August 14, 2025
August 1, 2024
2 years
September 10, 2024
August 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
French-PAPA
Psychometric properties (acceptability, internal validity, validity of structure against external criteria) of the French version of the PAPA questionnaire
0 day
Change of French-PAPA from baseline at 10 days
Test-retest reliability of the French version of the PAPA questionnaire
0 day, 10 days
Secondary Outcomes (6)
Hospital Anxiety and Depression Scale (HADS)
0 day
Perceived Stress Scale - 10 items (PSS-10)
0 day
General Health Questionnaire - 12 items (GHQ-12)
0 day
Dyadic Adjustment Scale - 4 items (DAS-4)
0 day
Socio-demographic and medical characteristics of male partners
0 day
- +1 more secondary outcomes
Eligibility Criteria
Women and their male partners whose wives have been consulted during the third trimester of pregnancy at the Clermont-Ferrand University Hospital Centre (France) or at one of the three private practices participating in the study and who wish to give birth at the Clermont-Ferrand University Hospital Centre and/or couples whose wives have given birth at the maternity unit of the Clermont-Ferrand University Hospital Centre.
You may qualify if:
- Woman and its male partner aged 18 years old and older
- Couple understanding, speaking and reading French
- Couple giving their informed consent to participate voluntarily
You may not qualify if:
- Woman without male partner
- Woman admitted to intensive care after giving birth
- Couple whose newborn died peripartum
- Couple who have had a medical abortion or fetal death in utero for the current pregnancy
- Woman and/or male partner refusing to participate in the study
- Woman and/or male partner not speaking French
- Woman and/or male partner in the incapacity to answer the questionnaires
- Woman and/or male partner under guardianship or conservatorship, deprived of liberty, or in the custody of correctional authorities
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Clermont-Ferrand
Clermont-Ferrand, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Françoise Vendittelli, PhD
Clermont-Ferrand University Hospital Centre
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 10, 2024
First Posted
September 19, 2024
Study Start
October 19, 2024
Primary Completion (Estimated)
October 18, 2026
Study Completion (Estimated)
November 18, 2026
Last Updated
August 14, 2025
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share